Overlapping area represents amount of risk that can be diversified away by holding Biovail Corp. Common Stoc and Acura Pharmaceuticals Inc. in the same portfolio (assuming nothing else is changed)
Valeant Pharmaceuticals International, Inc. raised bidding price from $6.50 to $7.50 per share in cash relevant to its earlier proposed price for the acquisition of ISTA Pharmaceuticals.
US stocks traded mixed Tuesday as the Dow Jones Industrial Average recently fell 33 points to 12676, the Standard & Poor's 500-stock index declined 1.4 points to 1315, and the Nasdaq Composite index gained 2.5 points to 2787.
Acura Pharmaceuticals Inc. (ACUR), a maker of technology to deter drug abuse, rose after its short-acting painkiller marketed by Pfizer Inc. (PFE) became commercially available.
US stocks traded lower Tuesday as the Dow Jones Industrial Average recently fell 50 points to 12659, the Standard & Poor's 500-stock index declined 5.4 points to 1311, and the Nasdaq Composite index was down 5.3 points to 2779.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
Filter Tops
Biovail Corp. Common Stoc and 
Acura Pharmaceuticals Inc.
Acura Pharmaceuticals Inc.
